COVID-19 : U.S. impact on antimicrobial resistance, special report 2022

doi:10.15620/cdc:117915

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

COVID-19 : U.S. impact on antimicrobial resistance, special report 2022

[PDF-10.66 MB]

Select the Download button to view the document

This document is over 5mb in size and cannot be previewed

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Division of Healthcare Quality Promotion.
Description:

During the COVID-19 pandemic, the detection and reporting of antimicrobial resistance data slowed tremendously because of changes in patient care, lab supply challenges, testing, treatment, and the bandwidth of healthcare facilities and health departments.

COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022, is a publication of the Antimicrobial Resistance Coordination and Strategy Unit within the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention.

Suggested citation: CDC. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/drugresistance/covid19.html

DOI:https://dx.doi.org/10.15620/cdc:117915

covid19-impact-report-508.pdf
Content Notes:

Foreword -- COVID-19 Impacts on Five Core Actions to Combat Antimicrobial Resistance Tracking and Data: Preventing Infections; Antibiotic Use; Environment (water, soil) and Sanitation; Vaccines, Diagnostics, and Therapeutics -- COVID-19 Impacts on 18 Antimicrobial-Resistant Bacteria and Fungi: Threat Estimates; Pathogen Summaries -- What’s Next: Building Public Health Capacity for Antimicrobial Resistance -- Technical Appendix: References; Data Methods.
Subjects:

[+]

Antimicrobial Stewardship COVID-19 Cross Infection Data Collection Drug Resistance, Microbial Hospitalization Pandemics Public Health Surveillance
Place as Subject:

United States
Pages in Document:

43 numbered pages
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:361e468f2ae8e2a32cc2e63eadcf473a5a2d391808f58d082b0b68ba6371182d
Download URL:

https://stacks.cdc.gov/view/cdc/119025/cdc_119025_DS1.pdf
File Type:

covid19.html

htm

More +